HMGB1 and glioma: Kaplan-Meier tests revealed that high HMGB1 levels correlate with poor glioma prognosis (Figure 6C-D), and correlation analysis showed that HMGB1 levels inversely correlate with miR-107 expression in glioma tissues (Figure 6E).